Autopsy report · NCT02478554

Antenatal Development Evaluated Prospectively

“Not IRB approved”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

The University of Texas Health Science Center, Houston

Sponsor type

University, hospital or other

Conditions

Retardation, Fetal Growth; Macrosomia, Fetal

Interventions

Customized fetal growth curves

Participants

0

Trials that died the same way

• Coronary Artery Study in Pediatric Heart Transplantation
  “never approved by IRB” (86% match in meaning)
• Changes in Bleeding and Clotting During the Menstrual Cycle
  “IRB Approval lapsed” (77% match in meaning)
• ASTHMAXcel Emergency Department Study
  “IRB approval expired” (74% match in meaning)
• Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics
  “Limited resources; IRB approval was not maintained” (74% match in meaning)
• Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea
  “Unable to obtain IRB approval at all sites” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.